Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization. (29th March 2023)
- Record Type:
- Journal Article
- Title:
- Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization. (29th March 2023)
- Main Title:
- Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization
- Authors:
- Assefa, Gebeyehu
Desta, Kassu
Araya, Shambel
Girma, Selfu
Hailu, Elena
Mihret, Adane
Hailu, Tsegaye
Tilahun, Melaku
Diriba, Getu
Dagne, Biniyam
Atnafu, Abay
Endalafer, Nigatu
Abera, Adugna
Bekele, Shiferaw
Mengistu, Yordanos
Bobosha, Kidist
Aseffa, Abraham - Other Names:
- Ivanyi Juraj Academic Editor.
- Abstract:
- Abstract : Background . Drug-resistant tuberculosis (TB) epidemic in high-TB-incidence countries, particularly Ethiopia, remains a significant challenge. As a result, we investigated the drug resistance, common gene mutation, and molecular characterization of mycobacterial isolates from patients with suspected tuberculous lymphadenitis (TBLN). Methodology . A cross-sectional study of 218 FNA samples from TBLN patients inoculated on Lowenstein-Jensen media was carried out. The culture isolates were identified as MTB by polymerase chain reaction (PCR) and the difference-9 (RD9) test region. In addition, the GenoType MTBDR plus assay tested the first and second-line MTB drugs, and the spoligotyping strain-dependent polymorphism test was determined. Results . Among the 50 culture-positive isolates, 14% (7/50) had drug resistance caused by a gene mutation. Out of these, 4 (8%) isolates were mono-resistant to isoniazid drug, which is caused by a gene mutation in katG in the region of interrogated at codon 315 in the amino acid sequence of S315T1, and 3 (6%) isolates were resistant to both rifampicin and isoniazid drugs. The mutation was observed for katG (at codon 315 with a change in the sequence of amino acid S315T) and rpoB (at codon 530–533 with a change in the sequence of amino acid S531L (S450L)) genes. The most prevalent spoligotypes were orphan and SIT53 strains. Conclusion . The predominance of INH mono-resistance poses a critical risk for the potential development ofAbstract : Background . Drug-resistant tuberculosis (TB) epidemic in high-TB-incidence countries, particularly Ethiopia, remains a significant challenge. As a result, we investigated the drug resistance, common gene mutation, and molecular characterization of mycobacterial isolates from patients with suspected tuberculous lymphadenitis (TBLN). Methodology . A cross-sectional study of 218 FNA samples from TBLN patients inoculated on Lowenstein-Jensen media was carried out. The culture isolates were identified as MTB by polymerase chain reaction (PCR) and the difference-9 (RD9) test region. In addition, the GenoType MTBDR plus assay tested the first and second-line MTB drugs, and the spoligotyping strain-dependent polymorphism test was determined. Results . Among the 50 culture-positive isolates, 14% (7/50) had drug resistance caused by a gene mutation. Out of these, 4 (8%) isolates were mono-resistant to isoniazid drug, which is caused by a gene mutation in katG in the region of interrogated at codon 315 in the amino acid sequence of S315T1, and 3 (6%) isolates were resistant to both rifampicin and isoniazid drugs. The mutation was observed for katG (at codon 315 with a change in the sequence of amino acid S315T) and rpoB (at codon 530–533 with a change in the sequence of amino acid S531L (S450L)) genes. The most prevalent spoligotypes were orphan and SIT53 strains. Conclusion . The predominance of INH mono-resistance poses a critical risk for the potential development of MDR-TB, as INH mono-resistance is a typical pathway to the occurrence of MDR-TB. The orphan and SIT53 (T) strains were the most common in the study area, and a drug-resistant strain caused by a common gene mutation could indicate the transmission of clonal-resistant strains in the community. … (more)
- Is Part Of:
- Tuberculosis research and treatment. Volume 2023(2023)
- Journal:
- Tuberculosis research and treatment
- Issue:
- Volume 2023(2023)
- Issue Display:
- Volume 2023, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 2023
- Issue:
- 2023
- Issue Sort Value:
- 2023-2023-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-03-29
- Subjects:
- Tuberculosis -- Periodicals
Tuberculosis -- Prevention -- Periodicals
Tuberculosis -- Treatment -- Periodicals
Tuberculosis -- Social aspects -- Periodicals
616.995005 - Journal URLs:
- https://www.hindawi.com/journals/trt/ ↗
- DOI:
- 10.1155/2023/3291538 ↗
- Languages:
- English
- ISSNs:
- 2090-150X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 27135.xml